Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: J Urol. 2010 Oct 16;184(6):2320–2327. doi: 10.1016/j.juro.2010.07.037

Table 4.

Results of the univariate analysis of the relationship between MR parameters and time to biochemical recurrence. The adjusted model accounted for the effect of clinical stage, biopsy Gleason score and PSA. HG, IG, LG = high grade, intermediate grade, low grade. A hazard ratio greater than 1.0 indicates an increased risk of biochemical recurrence with an increase in the variable of interest.

Covariate only model Adjusted model
HR 95% CI P value HR 95% CI P value
MRI risk score 2.33 (1.80 – 3.02) <0.0001 1.68 (1.15 – 1.24) 0.007
Index lesion variables:
 Mean CC/C ratio* 1.12 (1.02 – 1.23) 0.02 1.04 (0.93 – 1.16) 0.47
 # voxels in lesion 1.10 (1.06 – 1.13) <0.0001 1.07 (1.04 – 1.11) <0.0001
 Max CC/C ratio* 1.08 (1.03 – 1.12) 0.0003 1.04 (0.99 – 1.09) 0.06
 # HG voxels 1.10 (1.06 – 1.15) <0.0001 1.08 (1.03 – 1.13) 0.002
 # IG voxels 1.18 (1.12 – 1.25) <0.0001 1.13 (1.06 – 1.21) 0.003
 # LG voxels 1.08 (0.83 – 1.40) 0.58 1.09 (0.82 – 1.46) 0.56
 # HG + IG voxels 1.10 (1.06 – 1.13) <0.0001 1.07 (1.03 – 1.11) 0.0002
 % HG voxels 1.03 (1.02 – 1.13) <0.0001 1.02 (1.00 – 1.03) 0.03
 % IG voxels 1.00 (0.99 – 1.01) 0.57 1.0 (0.98 – 1.01) 0.51
 % LG voxels 0.97 (0.95 – 0.99) 0.009 0.98 (0.95 – 1.00) 0.08
 % HG+IG voxels 1.02 (1.00 – 1.03) 0.009 1.01 (0.99 – 1.02) 0.39
*

Mean and max CC/C values are based on the 117 patients in which an MRSI lesion was identified.